Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Luminescence | 1 | 2019 | 236 | 0.71 | Why? |
| Trans-Activators | 1 | 2019 | 170 | 0.69 | Why? |
| Luciferases | 1 | 2019 | 378 | 0.67 | Why? |
| Nanotechnology | 1 | 2019 | 821 | 0.48 | Why? |
| Cadmium | 2 | 2017 | 105 | 0.29 | Why? |
| Transcription Factor RelA | 2 | 2017 | 122 | 0.21 | Why? |
| Antibodies, Neutralizing | 8 | 2021 | 25288 | 0.21 | Why? |
| Hepatitis B virus | 2 | 2019 | 882 | 0.21 | Why? |
| Ceftazidime | 1 | 2021 | 134 | 0.20 | Why? |
| Plant Lectins | 1 | 2020 | 114 | 0.20 | Why? |
| Culture Media, Conditioned | 1 | 2019 | 66 | 0.19 | Why? |
| Antibodies, Monoclonal | 5 | 2021 | 8041 | 0.19 | Why? |
| Mice, Inbred ICR | 4 | 2021 | 242 | 0.18 | Why? |
| Microscopy, Fluorescence | 1 | 2019 | 335 | 0.18 | Why? |
| Hep G2 Cells | 1 | 2019 | 391 | 0.17 | Why? |
| Phosphoprotein Phosphatases | 1 | 2017 | 8 | 0.17 | Why? |
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2017 | 23 | 0.17 | Why? |
| Homeodomain Proteins | 1 | 2017 | 93 | 0.17 | Why? |
| JNK Mitogen-Activated Protein Kinases | 1 | 2017 | 59 | 0.17 | Why? |
| Peptide Library | 1 | 2020 | 564 | 0.16 | Why? |
| NADPH Oxidases | 1 | 2017 | 80 | 0.16 | Why? |
| Tumor Suppressor Proteins | 1 | 2017 | 165 | 0.16 | Why? |
| Triterpenes | 1 | 2017 | 199 | 0.14 | Why? |
| Nuclear Proteins | 1 | 2017 | 321 | 0.13 | Why? |
| Neoplasm Metastasis | 1 | 2017 | 682 | 0.13 | Why? |
| Neovascularization, Pathologic | 1 | 2017 | 305 | 0.13 | Why? |
| Viral Regulatory and Accessory Proteins | 1 | 2019 | 482 | 0.13 | Why? |
| Reactive Oxygen Species | 2 | 2017 | 1136 | 0.13 | Why? |
| Spike Glycoprotein, Coronavirus | 8 | 2021 | 37182 | 0.13 | Why? |
| Cell Line, Tumor | 2 | 2019 | 3608 | 0.12 | Why? |
| Single-Domain Antibodies | 1 | 2020 | 744 | 0.12 | Why? |
| Polysaccharides | 1 | 2020 | 854 | 0.12 | Why? |
| Neurons | 2 | 2017 | 864 | 0.11 | Why? |
| HEK293 Cells | 3 | 2021 | 8394 | 0.11 | Why? |
| Acetylcysteine | 1 | 2014 | 255 | 0.11 | Why? |
| Neuroprotective Agents | 1 | 2014 | 240 | 0.11 | Why? |
| Interleukin-8 | 1 | 2017 | 964 | 0.11 | Why? |
| Nanostructures | 1 | 2019 | 700 | 0.11 | Why? |
| Antibodies, Viral | 5 | 2021 | 51949 | 0.11 | Why? |
| Epitopes | 5 | 2021 | 4113 | 0.11 | Why? |
| Gene Expression Regulation, Viral | 1 | 2017 | 925 | 0.11 | Why? |
| Hepatitis B | 1 | 2019 | 888 | 0.11 | Why? |
| NF-kappa B | 1 | 2017 | 1301 | 0.10 | Why? |
| Mice | 8 | 2021 | 21357 | 0.09 | Why? |
| Nanoparticles | 1 | 2020 | 2040 | 0.09 | Why? |
| Apoptosis | 2 | 2017 | 2335 | 0.09 | Why? |
| Membrane Glycoproteins | 1 | 2017 | 2273 | 0.09 | Why? |
| Carcinoma, Hepatocellular | 1 | 2017 | 1222 | 0.08 | Why? |
| Mice, Nude | 2 | 2017 | 340 | 0.08 | Why? |
| Receptors, Virus | 2 | 2020 | 5659 | 0.08 | Why? |
| Protein Domains | 4 | 2021 | 6563 | 0.08 | Why? |
| Melanoma | 1 | 2017 | 1229 | 0.08 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.08 | Why? |
| Liver Neoplasms | 1 | 2017 | 1666 | 0.07 | Why? |
| Epitope Mapping | 2 | 2021 | 1240 | 0.07 | Why? |
| Mice, Inbred BALB C | 3 | 2021 | 5814 | 0.07 | Why? |
| Protein Stability | 2 | 2017 | 756 | 0.07 | Why? |
| K562 Cells | 1 | 2021 | 91 | 0.06 | Why? |
| Reproducibility of Results | 1 | 2019 | 11304 | 0.06 | Why? |
| Models, Molecular | 3 | 2021 | 7616 | 0.06 | Why? |
| Virus Internalization | 1 | 2020 | 7921 | 0.06 | Why? |
| Animals, Genetically Modified | 1 | 2021 | 230 | 0.06 | Why? |
| Specific Pathogen-Free Organisms | 1 | 2021 | 358 | 0.05 | Why? |
| Receptors, Cytokine | 1 | 2020 | 75 | 0.05 | Why? |
| THP-1 Cells | 1 | 2020 | 374 | 0.05 | Why? |
| Animals | 8 | 2021 | 78931 | 0.05 | Why? |
| Immunoglobulin Variable Region | 1 | 2020 | 253 | 0.05 | Why? |
| Immunoglobulin Heavy Chains | 1 | 2020 | 222 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.05 | Why? |
| Ubiquitin-Specific Peptidase 7 | 1 | 2017 | 5 | 0.05 | Why? |
| Primates | 1 | 2021 | 584 | 0.05 | Why? |
| Liver Neoplasms, Experimental | 1 | 2017 | 17 | 0.05 | Why? |
| Conserved Sequence | 1 | 2021 | 751 | 0.04 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.04 | Why? |
| Tripterygium | 1 | 2017 | 15 | 0.04 | Why? |
| Pentacyclic Triterpenes | 1 | 2017 | 45 | 0.04 | Why? |
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2020 | 290 | 0.04 | Why? |
| Neoplasms, Experimental | 1 | 2017 | 67 | 0.04 | Why? |
| Inhibitory Concentration 50 | 1 | 2020 | 907 | 0.04 | Why? |
| Drug Synergism | 1 | 2020 | 833 | 0.04 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2017 | 274 | 0.04 | Why? |
| Brain | 1 | 2014 | 5133 | 0.04 | Why? |
| SARS Virus | 1 | 2021 | 13021 | 0.04 | Why? |
| Transcriptional Activation | 1 | 2017 | 196 | 0.04 | Why? |
| Antibody-Dependent Enhancement | 1 | 2021 | 413 | 0.04 | Why? |
| NADPH Oxidase 2 | 1 | 2017 | 58 | 0.04 | Why? |
| Neutralization Tests | 2 | 2021 | 6698 | 0.04 | Why? |
| Immunoglobulin Fc Fragments | 1 | 2020 | 691 | 0.04 | Why? |
| Cell Membrane | 1 | 2020 | 743 | 0.04 | Why? |
| Cell Line | 2 | 2021 | 12040 | 0.04 | Why? |
| Random Allocation | 1 | 2017 | 773 | 0.04 | Why? |
| Cell Nucleus | 1 | 2017 | 399 | 0.03 | Why? |
| Vaccines, Inactivated | 1 | 2021 | 1562 | 0.03 | Why? |
| Protein Binding | 2 | 2021 | 11430 | 0.03 | Why? |
| Cell Movement | 1 | 2017 | 695 | 0.03 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2021 | 2134 | 0.03 | Why? |
| Cryoelectron Microscopy | 1 | 2021 | 2372 | 0.03 | Why? |
| Proteolysis | 1 | 2017 | 751 | 0.03 | Why? |
| Humans | 14 | 2021 | 930598 | 0.03 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 372 | 0.03 | Why? |
| TOR Serine-Threonine Kinases | 1 | 2014 | 385 | 0.03 | Why? |
| Macaca mulatta | 1 | 2021 | 3716 | 0.03 | Why? |
| Mice, Inbred C57BL | 1 | 2021 | 5542 | 0.03 | Why? |
| Protein Conformation | 1 | 2021 | 4386 | 0.02 | Why? |
| Cross Reactions | 1 | 2021 | 4374 | 0.02 | Why? |
| Rats | 1 | 2017 | 2764 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2021 | 6049 | 0.02 | Why? |
| Signal Transduction | 2 | 2017 | 7207 | 0.02 | Why? |
| Virion | 1 | 2017 | 1444 | 0.02 | Why? |
| Molecular Targeted Therapy | 1 | 2017 | 1579 | 0.02 | Why? |
| Immunologic Memory | 1 | 2020 | 3362 | 0.02 | Why? |
| Monocytes | 1 | 2020 | 2978 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Drug Delivery Systems | 1 | 2017 | 1365 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2020 | 4418 | 0.02 | Why? |
| Viral Envelope Proteins | 1 | 2017 | 3539 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Oxidative Stress | 1 | 2014 | 2050 | 0.02 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.01 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.01 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.01 | Why? |
| Female | 4 | 2021 | 380317 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.01 | Why? |
| Virus Replication | 1 | 2017 | 14331 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Male | 3 | 2020 | 367725 | 0.01 | Why? |
| Adult | 1 | 2020 | 244371 | 0.00 | Why? |
| Middle Aged | 1 | 2020 | 270681 | 0.00 | Why? |
Gu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(134)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(206)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_